E-LIB Suche - Ergebnisse für: Gatzweiler, Charlotte

1

Class I HDAC inhibitor entinostat synergizes with PLK1 inhi..:

Valinciute, Gintvile ; Ecker, Jonas ; Selt, Florian...
Journal of Neuro-Oncology. 163 (2023) 1 - p. 143-158 , 2023

Link: https://doi.org/10.1007/..

2

LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-5..:

Sigaud, Romain ; Rösch, Lisa ; Gatzweiler, Charlotte...
Neuro-Oncology. 24 (2022) Supplement_1 - p. i93-i93 , 2022

Link: https://doi.org/10.1093/..

3

Functional Therapeutic Target Validation Using Pediatric Ze..:

Gatzweiler, Charlotte ; Ridinger, Johannes ; Herter, Sonja...
Cancers. 14 (2022) 3 - p. 849 , 2022

Link: https://doi.org/10.3390/..

4

The first-in-class ERK inhibitor ulixertinib shows promisin..:

Sigaud, Romain ; Rösch, Lisa ; Gatzweiler, Charlotte...
Neuro-Oncology. 25 (2022) 3 - p. 566-579 , 2022

Link: https://doi.org/10.1093/..

5

Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Tre..:

Müller, Michael ; Rösch, Lisa ; Najafi, Sara...
Cancers. 13 (2021) 17 - p. 4476 , 2021

Link: https://doi.org/10.3390/..

6

EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERG..:

Valinciute, Gintvile ; Ecker, Jonas ; Selt, Florian...
Neuro-Oncology. 23 (2021) Supplement_1 - p. i5-i5 , 2021

Link: https://doi.org/10.1093/..

7

Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments..:

Wrobel, Jagoda K ; Najafi, Sara ; Ayhan, Simay...
Pharmaceuticals. 13 (2020) 11 - p. 345 , 2020

Link: https://doi.org/10.3390/..

8

Class I HDAC inhibitor entinostat synergizes with PLK1 inhi..:

Valinciute, Gintvile ; Ecker, Jonas ; Selt, Florian...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s11060-023-04319-1. , 2023

Link: https://cnrs.hal.science..

9

Class I HDAC inhibitor entinostat synergizes with PLK1 inhi..:

Valinciute, Gintvile ; Ecker, Jonas ; Selt, Florian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232604/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Class I HDAC inhibitor entinostat synergizes with PLK1 inhi..:

Valinciute, Gintvile ; Ecker, Jonas ; Selt, Florian...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s11060-023-04319-1. , 2023

Link: https://cnrs.hal.science..

11

LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-5..:

Sigaud, Romain ; Rösch, Lisa ; Gatzweiler, Charlotte...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164732/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Functional Therapeutic Target Validation Using Pediatric Ze..:

Charlotte Gatzweiler ; Johannes Ridinger ; Sonja Herter...
https://www.mdpi.com/2072-6694/14/3/849. , 2022

Link: https://doi.org/10.3390/..

13

Functional Therapeutic Target Validation Using Pediatric Ze..:

Charlotte Gatzweiler ; Johannes Ridinger ; Sonja Herter...
https://dx.doi.org/10.3390/cancers14030849. , 2022

Link: https://doi.org/10.3390/..

14

Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Tre..:

Michael Müller ; Lisa Rösch ; Sara Najafi...
https://www.mdpi.com/2072-6694/13/17/4476. , 2021

Link: https://doi.org/10.3390/..

15

Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Tre..:

Michael Müller ; Lisa Rösch ; Sara Najafi...
Pediatric Oncology. , 2021

Link: https://doi.org/10.3390/..